0001752724-21-069401.txt : 20210401 0001752724-21-069401.hdr.sgml : 20210401 20210331205902 ACCESSION NUMBER: 0001752724-21-069401 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210131 FILED AS OF DATE: 20210401 PERIOD START: 20211031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) CENTRAL INDEX KEY: 0000880859 IRS NUMBER: 760352823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-06463 FILM NUMBER: 21795635 BUSINESS ADDRESS: STREET 1: 11 GREENWAY PLAZA STREET 2: SUITE 1000 CITY: HOUSTON STATE: TX ZIP: 77046 BUSINESS PHONE: 7136261919 MAIL ADDRESS: STREET 1: 11 GREENWAY PLAZA STREET 2: SUITE 1000 CITY: HOUSTON STATE: TX ZIP: 77046 FORMER COMPANY: FORMER CONFORMED NAME: AIM INTERNATIONAL MUTUAL FUNDS DATE OF NAME CHANGE: 20031126 FORMER COMPANY: FORMER CONFORMED NAME: AIM INTERNATIONAL FUNDS INC /MD/ DATE OF NAME CHANGE: 20000620 FORMER COMPANY: FORMER CONFORMED NAME: AIM INTERNATIONAL MUTUAL FUNDS DATE OF NAME CHANGE: 20000323 0000880859 S000064624 Invesco Global Fund C000209205 Class C C000209206 Class R C000209207 Class Y C000209208 Class R5 C000209209 Class R6 C000209210 Class A NPORT-P 1 primary_doc.xml NPORT-P false 0000880859 XXXXXXXX S000064624 C000209207 C000209208 C000209206 C000209205 C000209209 C000209210 AIM International Mutual Funds (Invesco International Mutual Funds) 811-06463 0000880859 549300CGSTEJJ7H1ET84 11 Greenway Plaza Suite 1000 Houston 77046-1173 800-959-4246 Invesco Global Fund S000064624 549300OZR8OUIKYYPI86 2021-10-31 2021-01-31 N 12432219058.06 26953431.58 12405265626.48 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 8022926.31000000 N Invesco Treasury Portfolio 5493004B3TM8ZIDDDC39 Invesco Treasury Portfolio, Institutional Class 825252406 11566218.57000000 NS USD 11566218.57000000 0.093236363639 Long STIV RF US N 1 N N N Industria de Diseno Textil S.A. 549300TTCXZOGZM2EY83 Industria de Diseno Textil S.A. N/A 4822745.00000000 NS 143086194.64000000 1.153431123107 Long EC CORP ES N 2 N N N Kering S.A. 549300VGEJKB7SVUZR78 Kering S.A. F5433L103 458595.00000000 NS 300940997.70000000 2.425913372282 Long EC CORP FR N 2 N N N Alphabet, Inc. 5493006MHB84DD0ZWV18 Alphabet, Inc., Class A 02079K305 615013.00000000 NS USD 1123850155.68000000 9.059460631629 Long EC CORP US N 1 N N N Ionis Pharmaceuticals, Inc. 549300SI4ZGLG0BLUZ92 Ionis Pharmaceuticals, Inc. 462222100 1240416.00000000 NS USD 74511789.12000000 0.600646462264 Long EC CORP US N 1 N N N PayPal Holdings, Inc. 5493005X2GO78EFZ3E94 PayPal Holdings, Inc. 70450Y103 1593609.00000000 NS USD 373398524.79000000 3.010000237261 Long EC CORP US N 1 N N N uniQure N.V. N/A uniQure N.V. N90064101 1031898.00000000 NS USD 36539508.18000000 0.294548373893 Long EC CORP NL N 1 N N N Equifax, Inc. 5493004MCF8JDC86VS77 Equifax, Inc. 294429105 1047869.00000000 NS USD 185588078.59000000 1.496042762630 Long EC CORP US N 1 N N N Amazon.com, Inc. ZXTILKJKG63JELOEG630 Amazon.com, Inc. 023135106 53288.00000000 NS USD 170851985.60000000 1.377253746467 Long EC CORP US N 1 N N N FANUC Corp. 529900QTSW745LOKW705 FANUC Corp. N/A 598400.00000000 NS 157143917.31000000 1.266751733026 Long EC CORP JP N 2 N N N Boston Scientific Corp. Y6ZDD9FP4P8JSSJMW954 Boston Scientific Corp. 101137107 1675490.00000000 NS USD 59379365.60000000 0.478662588838 Long EC CORP US N 1 N N N Intuit, Inc. VI90HBPH7XSFMB9E4M29 Intuit, Inc. 461202103 1384920.00000000 NS USD 500274651.60000000 4.032760495931 Long EC CORP US N 1 N N N Charles River Laboratories International, Inc. 549300BSQ0R4UZ5KX287 Charles River Laboratories International, Inc. 159864107 188480.00000000 NS USD 48825744.00000000 0.393588863553 Long EC CORP US N 1 N N N Phathom Pharmaceuticals, Inc. N/A Phathom Pharmaceuticals, Inc. 71722W107 1123410.00000000 NS USD 43251285.00000000 0.348652631086 Long EC CORP US N 1 N N N Reservas de Maternidad - Swiss Medical N/A Reservas de Maternidad - Swiss Medical N/A 1029617880.03000000 NS USD 32894232.03000000 0.265163463809 Long EC CORP AR N 3 N N N Invesco Government & Agency Portfolio 5493007T1J7WZ5QI1A47 Invesco Government & Agency Portfolio, Institutional Class 825252885 10120441.30000000 NS USD 10120441.30000000 0.081581818598 Long STIV RF US N 1 N N N Dassault Systemes S.E. 96950065LBWY0APQIM86 Dassault Systemes S.E. N/A 178332.00000000 NS 35653254.32000000 0.287404199099 Long EC CORP FR N 2 N N N Blueprint Medicines Corp. 5299004CC60O9T5HVM83 Blueprint Medicines Corp. 09627Y109 666014.00000000 NS USD 64436854.50000000 0.519431477246 Long EC CORP US N 1 N N N MacroGenics, Inc. 5493001KJQUA83L8MH79 MacroGenics, Inc. 556099109 1045323.00000000 NS USD 21366402.12000000 0.172236554728 Long EC CORP US N 1 N N N Murata Manufacturing Co., Ltd. 529900QZG6DL8ZRI7140 Murata Manufacturing Co., Ltd. N/A 4330212.00000000 NS 417041865.90000000 3.361813269115 Long EC CORP JP N 2 N N N Farfetch Ltd. 549300QFQ74Z0F96NS78 Farfetch Ltd., Class A 30744W107 3126870.00000000 NS USD 191489518.80000000 1.543614821042 Long EC CORP KY N 1 N N N United Parcel Service, Inc. D01LMJZU09ULLNCY6Z23 United Parcel Service, Inc., Class B 911312106 1263180.00000000 NS USD 195792900.00000000 1.578304777142 Long EC CORP US N 1 N N N Brunello Cucinelli S.p.A. 5493003CX2RZ0FOBH256 Brunello Cucinelli S.p.A. N/A 773116.00000000 NS 30962711.81000000 0.249593299670 Long EC CORP IT N 2 N N N Sage Therapeutics, Inc. 5493000JX4BJS9W6CN35 Sage Therapeutics, Inc. 78667J108 450794.00000000 NS USD 36356536.10000000 0.293073418939 Long EC CORP US N 1 N N N Pegasystems, Inc. 549300FMCOKPL06FYN26 Pegasystems, Inc. 705573103 590801.00000000 NS USD 75297587.45000000 0.606980855688 Long EC CORP US N 1 N N N Twist Bioscience Corp. 549300T23BL59LCOH584 Twist Bioscience Corp. 90184D100 58158.00000000 NS USD 9569317.32000000 0.077139156936 Long EC CORP US N 1 N N N Illumina, Inc. SQ95QG8SR5Q56LSNF682 Illumina, Inc. 452327109 223661.00000000 NS USD 95377996.84000000 0.768850903413 Long EC CORP US N 1 N N N Nuance Communications, Inc. AEMSOT3SS15TNMJCE605 Nuance Communications, Inc. 67020Y100 1578159.00000000 NS USD 71869360.86000000 0.579345602294 Long EC CORP US N 1 N N N Fate Therapeutics, Inc. 549300L14Q4UHOODLA90 Fate Therapeutics, Inc. 31189P102 296684.00000000 NS USD 26888470.92000000 0.216750464920 Long EC CORP US N 1 N N N Castle Biosciences, Inc. N/A Castle Biosciences, Inc. 14843C105 406818.00000000 NS USD 27187646.94000000 0.219162150643 Long EC CORP US N 1 N N N Adobe, Inc. FU4LY2G4933NH2E1CP29 Adobe, Inc. 00724F101 1091454.00000000 NS USD 500726351.58000000 4.036401691481 Long EC CORP US N 1 N N N Atlas Copco AB 213800T8PC8Q4FYJZR07 Atlas Copco AB, Class A N/A 3998937.00000000 NS 217678520.84000000 1.754726802264 Long EC CORP SE N 2 N N N LVMH Moet Hennessy Louis Vuitton SE IOG4E947OATN0KJYSD45 LVMH Moet Hennessy Louis Vuitton SE N/A 1040130.00000000 NS 628023389.81000000 5.062554956255 Long EC CORP FR N 2 N N N S&P Global, Inc. Y6X4K52KMJMZE7I7MY94 S&P Global, Inc. 78409V104 1519633.00000000 NS USD 481723661.00000000 3.883219235319 Long EC CORP US N 1 N N N Facebook, Inc. BQ4BKCS1HXDV9HN80Z93 Facebook, Inc., Class A 30303M102 2050329.00000000 NS USD 529661490.57000000 4.269650538069 Long EC CORP US N 1 N N N Ascendis Pharma A/S 549300B66JN3W3J8GH73 Ascendis Pharma A/S, ADR 04351P101 51902.00000000 NS USD 7793085.30000000 0.062820785420 Long EC CORP DK N 1 N N N SAP S.E. 529900D6BF99LW9R2E68 SAP S.E. D66992104 2404878.00000000 NS 306137719.13000000 2.467804627065 Long EC CORP DE N 2 N N N Airbus S.E. MINO79WLOO247M1IL051 Airbus S.E. N/A 3129088.00000000 NS 315236778.52000000 2.541152991090 Long EC CORP NL N 2 N N N Analog Devices, Inc. GYVOE5EZ4GDAVTU4CQ61 Analog Devices, Inc. 032654105 172447.00000000 NS USD 25406616.51000000 0.204805098697 Long EC CORP US N 1 N N N Maxim Integrated Products, Inc. SO0H5YEO14Y4PVKQH532 Maxim Integrated Products, Inc. 57772K101 3892205.00000000 NS USD 341385300.55000000 2.751938659187 Long EC CORP US N 1 N N N Colgate-Palmolive Co. YMEGZFW4SBUSS5BQXF88 Colgate-Palmolive Co. 194162103 324518.00000000 NS USD 25312404.00000000 0.204045642891 Long EC CORP US N 1 N N N Zimmer Biomet Holdings, Inc. 2P2YLDVPES3BXQ1FRB91 Zimmer Biomet Holdings, Inc. 98956P102 247985.00000000 NS USD 38107854.95000000 0.307190963075 Long EC CORP US N 1 N N N ICICI Bank Ltd. R7RX8ER1V4666J8D1I38 ICICI Bank Ltd., ADR 45104G104 11904539.00000000 NS USD 179758538.90000000 1.449050300997 Long EC CORP IN N 1 N N N Keyence Corp. 529900M7PQBS7A89DZ11 Keyence Corp. N/A 656012.00000000 NS 352895884.66000000 2.844726548270 Long EC CORP JP N 2 N N N Zee Entertainment Enterprises Ltd. 254900EQIYPXZEO10B94 Zee Entertainment Enterprises Ltd., Pfd. EP0457648 15040130.00000000 NS 828691.37000000 0.006680158208 Long EP CORP IN N 1 N N N Omron Corp. 549300ZHW0TR2QZ0NY83 Omron Corp. N/A 2246400.00000000 NS 198850303.72000000 1.602950792891 Long EC CORP JP N 2 N N N IQVIA Holdings, Inc. 549300W3R20NM4KQPH86 IQVIA Holdings, Inc. 46266C105 356418.00000000 NS USD 63371120.40000000 0.510840495545 Long EC CORP US N 1 N N N Agilent Technologies, Inc. QUIX8Y7A2WP0XRMW7G29 Agilent Technologies, Inc. 00846U101 1856680.00000000 NS USD 223117235.60000000 1.798568787787 Long EC CORP US N 1 N N N DLF Ltd. 335800PJLUEOB8914F48 DLF Ltd. N/A 70355450.00000000 NS 246200060.41000000 1.984641585460 Long EC CORP IN N 2 N N N Assa Abloy AB 549300YECS8HKCIMMB67 Assa Abloy AB, Class B N/A 6401588.00000000 NS 158496197.41000000 1.277652588685 Long EC CORP SE N 2 N N N Walt Disney Co. (The) 549300GZKULIZ0WOW665 Walt Disney Co. (The) 254687106 1447460.00000000 NS USD 243419348.20000000 1.962226005708 Long EC CORP US N 1 N N N Microsoft Corp. INR2EJN1ERAN0W5ZP974 Microsoft Corp. 594918104 571949.00000000 NS USD 132669290.04000000 1.069459486274 Long EC CORP US N 1 N N N Invesco Liquid Assets Portfolio 549300DC1W0JSX3QRC47 Invesco Liquid Assets Portfolio, Institutional Class 825252729 7225871.69800000 NS USD 7228762.05000000 0.058271723215 Long STIV RF US N 1 N N N Nidec Corp. 353800IF171MZTNL6Y31 Nidec Corp. N/A 3819432.00000000 NS 507255947.07000000 4.089037368028 Long EC CORP JP N 2 N N N Prudential PLC 5493001Z3ZE83NGK8Y12 Prudential PLC N/A 7726408.00000000 NS 123864404.68000000 0.998482486466 Long EC CORP GB N 2 N N N Avantor, Inc. 5493003VM0XB4U8YD238 Avantor, Inc. 05352A100 5874297.00000000 NS USD 173233018.53000000 1.396447474371 Long EC CORP US N 1 N N N Dun & Bradstreet Holdings, Inc. N/A Dun & Bradstreet Holdings, Inc. 26484T106 702338.00000000 NS USD 16610293.70000000 0.133897122400 Long EC CORP US N 1 N N N ASML Holding N.V. 724500Y6DUVHQD6OXN27 ASML Holding N.V. N07059202 127086.00000000 NS 67663704.43000000 0.545443414654 Long EC CORP NL N 2 N N N JD.com, Inc. 549300HVTWB0GJZ16V92 JD.com, Inc., ADR 47215P106 6161480.00000000 NS USD 546461661.20000000 4.405078276063 Long EC CORP KY N 1 N N N Visa, Inc. 549300JZ4OKEHW3DPJ59 Visa, Inc., Class A 92826C839 615172.00000000 NS USD 118881989.00000000 0.958318770266 Long EC CORP US N 1 N N N StoneCo Ltd. 549300O1A9LEF0XZCR35 StoneCo Ltd., Class A G85158106 1713077.00000000 NS USD 123170236.30000000 0.992886730591 Long EC CORP KY N 1 N N N Electronic Arts, Inc. 549300O7A67PUEYKDL45 Electronic Arts, Inc. 285512109 789437.00000000 NS USD 113047378.40000000 0.911285431556 Long EC CORP US N 1 N N N Zur Rose Group AG 50670038OH136R5Z4663 Zur Rose Group AG N/A 172835.00000000 NS 79378614.90000000 0.639878397529 Long EC CORP CH N 2 N N N Capcom Co Ltd. 529900JJWQKXS3TC8744 Capcom Co Ltd. N/A 2856600.00000000 NS 179428638.93000000 1.446390946655 Long EC CORP JP N 2 N N N Takeda Pharmaceutical Co. Ltd. 549300ZLMVP4X0OGR454 Takeda Pharmaceutical Co. Ltd. N/A 2622189.00000000 NS 91940200.64000000 0.741138508503 Long EC CORP JP N 2 N N N TDK Corp. 3538005O8WNU39U8NX03 TDK Corp. N/A 1587300.00000000 NS 256957364.23000000 2.071357212065 Long EC CORP JP N 2 N N N Fidelity National Information Services, Inc. 6WQI0GK1PRFVBA061U48 Fidelity National Information Services, Inc. 31620M106 1031570.00000000 NS USD 127357632.20000000 1.026641718401 Long EC CORP US N 1 N N N Veracyte, Inc. 529900ESWZRHXOW27Z37 Veracyte, Inc. 92337F107 1487213.00000000 NS USD 84324977.10000000 0.679751483273 Long EC CORP US N 1 N N N Qualtrics International, Inc. 549300NW34K5PVZGTN68 Qualtrics International, Inc., Class A 747601201 249964.00000000 NS USD 10998416.00000000 0.088659254313 Long EC CORP US N 1 N N N 2021-03-02 AIM International Mutual Funds (Invesco International Mutual Funds) Sheri Morris Sheri Morris President XXXX NPORT-EX 2 edgar.htm
Schedule of Investments
January 31, 2021
(Unaudited)
  Shares Value
Common Stocks & Other Equity Interests–99.87%
Argentina–0.27%
Reservas de Maternidad - Swiss Medical(a)(b) 1,029,617,880     $32,894,232
Brazil–0.99%
StoneCo Ltd., Class A(c) 1,713,077    123,170,236
China–4.41%
JD.com, Inc., ADR(c) 6,161,480    546,461,661
Denmark–0.06%
Ascendis Pharma A/S, ADR(c) 51,902      7,793,085
France–10.32%
Airbus SE(c) 3,129,088    315,236,778
Dassault Systemes SE 178,332     35,653,254
Kering S.A. 458,595    300,940,998
LVMH Moet Hennessy Louis Vuitton SE 1,040,130    628,023,390
      1,279,854,420
Germany–2.47%
SAP SE 2,404,878    306,137,719
India–3.44%
DLF Ltd. 70,355,450    246,200,059
ICICI Bank Ltd., ADR 11,904,539    179,758,540
      425,958,599
Italy–0.25%
Brunello Cucinelli S.p.A.(c) 773,116     30,962,712
Japan–17.43%
Capcom Co. Ltd. 2,856,600    179,428,639
FANUC Corp. 598,400    157,143,917
Keyence Corp. 656,012    352,895,885
Murata Manufacturing Co. Ltd. 4,330,212    417,041,866
Nidec Corp. 3,819,432    507,255,947
Omron Corp. 2,246,400    198,850,304
Takeda Pharmaceutical Co. Ltd. 2,622,189     91,940,201
TDK Corp. 1,587,300    256,957,364
      2,161,514,123
Netherlands–0.84%
ASML Holding N.V. 127,086     67,663,705
uniQure N.V.(c) 1,031,898     36,539,508
      104,203,213
Spain–1.15%
Industria de Diseno Textil S.A. 4,822,745    143,086,195
Sweden–3.03%
Assa Abloy AB, Class B 6,401,588    158,496,197
Atlas Copco AB, Class A 3,998,937    217,678,521
      376,174,718
Switzerland–0.64%
Zur Rose Group AG(c) 172,835     79,378,615
  Shares Value
United Kingdom–2.54%
Farfetch Ltd., Class A(c) 3,126,870    $191,489,519
Prudential PLC 7,726,408    123,864,405
      315,353,924
United States–52.03%
Adobe, Inc.(c) 1,091,454    500,726,352
Agilent Technologies, Inc. 1,856,680    223,117,236
Alphabet, Inc., Class A(c) 615,013  1,123,850,156
Amazon.com, Inc.(c) 53,288    170,851,986
Analog Devices, Inc. 172,447     25,406,616
Avantor, Inc.(c) 5,874,297    173,233,018
Blueprint Medicines Corp.(c) 666,014     64,436,854
Boston Scientific Corp.(c) 1,675,490     59,379,366
Castle Biosciences, Inc.(c) 406,818     27,187,647
Charles River Laboratories International, Inc.(c) 188,480     48,825,744
Colgate-Palmolive Co. 324,518     25,312,404
Dun & Bradstreet Holdings, Inc.(c) 702,338     16,610,294
Electronic Arts, Inc. 789,437    113,047,378
Equifax, Inc. 1,047,869    185,588,079
Facebook, Inc., Class A(c) 2,050,329    529,661,491
Fate Therapeutics, Inc.(c) 296,684     26,888,471
Fidelity National Information Services, Inc. 1,031,570    127,357,632
Illumina, Inc.(c) 223,661     95,377,997
Intuit, Inc. 1,384,920    500,274,652
Ionis Pharmaceuticals, Inc.(c) 1,240,416     74,511,789
IQVIA Holdings, Inc.(c) 356,418     63,371,120
MacroGenics, Inc.(c) 1,045,323     21,366,402
Maxim Integrated Products, Inc. 3,892,205    341,385,300
Microsoft Corp. 571,949    132,669,290
Nuance Communications, Inc.(c) 1,578,159     71,869,361
PayPal Holdings, Inc.(c) 1,593,609    373,398,525
Pegasystems, Inc. 590,801     75,297,587
Phathom Pharmaceuticals, Inc.(c) 1,123,410     43,251,285
Qualtrics International, Inc., Class A 249,964     10,998,416
S&P Global, Inc. 1,519,633    481,723,661
Sage Therapeutics, Inc.(c) 450,794     36,356,536
Twist Bioscience Corp.(c) 58,158      9,569,317
United Parcel Service, Inc., Class B 1,263,180    195,792,900
Veracyte, Inc.(c) 1,487,213     84,324,977
Visa, Inc., Class A 615,172    118,881,989
Walt Disney Co. (The) 1,447,460    243,419,348
Zimmer Biomet Holdings, Inc. 247,985     38,107,855
      6,453,429,031
Total Common Stocks & Other Equity Interests (Cost $4,338,407,039) 12,386,372,483
Preferred Stocks–0.01%
India–0.01%
Zee Entertainment Enterprises Ltd., 6.00%, Pfd.
(Cost $0) 		15,040,130        828,691
 
See accompanying notes which are an integral part of this schedule.
Invesco Global Fund
  Shares Value
Money Market Funds–0.23%
Invesco Government & Agency Portfolio, Institutional Class, 0.03%(a)(d) 10,120,441     $10,120,441
Invesco Liquid Assets Portfolio, Institutional Class, 0.05%(a)(d) 7,225,872      7,228,762
Invesco Treasury Portfolio, Institutional Class, 0.01%(a)(d) 11,566,219     11,566,219
Total Money Market Funds (Cost $28,915,422) 28,915,422
TOTAL INVESTMENTS IN SECURITIES—100.11% (Cost $4,367,322,461) 12,416,116,596
OTHER ASSETS LESS LIABILITIES–(0.11)% (13,672,578)
NET ASSETS–100.00% $12,402,444,018
Investment Abbreviations:
ADR – American Depositary Receipt
Pfd. – Preferred
Notes to Schedule of Investments:
(a) Affiliated issuer. The issuer is affiliated by having an investment adviser that is under common control of Invesco Ltd. and/or the Investment Company Act of 1940, as amended (the “1940 Act”), defines “affiliated person” to include an issuer of which a fund holds 5% or more of the outstanding voting securities. The Fund has not owned enough of the outstanding voting securities of the issuer to have control (as defined in the 1940 Act) of that issuer. The table below shows the Fund’s transactions in, and earnings from, its investments in affiliates for the three months ended January 31, 2021.
    
  Value
October 31, 2020 		Purchases
at Cost 		Proceeds
from Sales 		Change in
Unrealized
Appreciation
(Depreciation) 		Realized
Gain
(Loss) 		Value
January 31, 2021 		Dividend Income
Investments in Affiliated Money Market Funds:              
Invesco Government & Agency Portfolio, Institutional Class $4,269,509 $94,443,875 $(88,592,943) $- $- $10,120,441 $401
Invesco Liquid Assets Portfolio, Institutional Class 3,048,843 67,459,912 (63,279,969) 192 (216) 7,228,762 1,006
Invesco Treasury Portfolio, Institutional Class 4,879,438 107,935,859 (101,249,078) - - 11,566,219 245
Investments in Other Affiliates:              
Reservas de Maternidad - Swiss Medical 36,663,663 - - (3,769,431) - 32,894,232 -
Total $48,861,453 $269,839,646 $(253,121,990) $(3,769,239) $(216) $61,809,654 $1,652
    
(b) Security valued using significant unobservable inputs (Level 3). See Note 1.
(c) Non-income producing security.
(d) The rate shown is the 7-day SEC standardized yield as of January 31, 2021.
The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.
See accompanying notes which are an integral part of this schedule.
Invesco Global Fund
Notes to Quarterly Schedule of Portfolio Holdings
January 31, 2021
(Unaudited)
NOTE 1—Additional Valuation Information
Generally Accepted Accounting Principles ("GAAP") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under current market conditions. GAAP establishes a hierarchy that prioritizes the inputs to valuation methods, giving the highest priority to readily available unadjusted quoted prices in an active market for identical assets (Level 1) and the lowest priority to significant unobservable inputs (Level 3), generally when market prices are not readily available or are unreliable. Based on the valuation inputs, the securities or other investments are tiered into one of three levels. Changes in valuation methods may result in transfers in or out of an investment’s assigned level:
Level 1 — Prices are determined using quoted prices in an active market for identical assets.
Level 2 — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants may use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, loss severities, default rates, discount rates, volatilities and others.
Level 3 — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used. Unobservable inputs reflect the Fund’s own assumptions about the factors market participants would use in determining fair value of the securities or instruments and would be based on the best available information.
The following is a summary of the tiered valuation input levels, as of January 31, 2021. The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities. Because of the inherent uncertainties of valuation, the values reflected in the financial statements may materially differ from the value received upon actual sale of those investments.
  Level 1 Level 2 Level 3 Total
Investments in Securities        
Argentina $— $— $32,894,232 $32,894,232
Brazil 123,170,236 — — 123,170,236
China 546,461,661 — — 546,461,661
Denmark 7,793,085 — — 7,793,085
France — 1,279,854,420 — 1,279,854,420
Germany — 306,137,719 — 306,137,719
India 180,587,231 246,200,059 — 426,787,290
Italy — 30,962,712 — 30,962,712
Japan — 2,161,514,123 — 2,161,514,123
Netherlands 36,539,508 67,663,705 — 104,203,213
Spain — 143,086,195 — 143,086,195
Sweden — 376,174,718 — 376,174,718
Switzerland — 79,378,615 — 79,378,615
United Kingdom 191,489,519 123,864,405 — 315,353,924
United States 6,453,429,031 — — 6,453,429,031
Money Market Funds 28,915,422 — — 28,915,422
Total Investments $7,568,385,693 $4,814,836,671 $32,894,232 $12,416,116,596
NOTE 2—Coronavirus (COVID-19) Pandemic
During the first quarter of 2020, the World Health Organization declared COVID-19 to be a public health emergency. COVID-19 has led to increased short-term market volatility and may have adverse long-term effects on U.S. and world economies and markets in general. COVID-19 may adversely impact the Fund’s ability to achieve its investment objective, as stated in the most recent shareholder report. Because of the uncertainties on valuation, the global economy and business operations, values reflected in the Schedule of Investments may materially differ from the value received upon actual sales of those investments.
The extent of the impact on the performance of the Fund and its investments will depend on future developments, including the duration and spread of the COVID-19 outbreak, related restrictions and advisories, and the effects on the financial markets and economy overall, all of which are highly uncertain and cannot be predicted.
Invesco Global Fund